Status | Study |
Recruiting |
Study Name: Citicoline Effect on Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) Condition: Non-arteritic Anterior Ischemic Optic Neuropathy Date: 2017-02-05 Interventions: Drug: Group A Citicoline 1000 mg oral tablet |
Recruiting |
Study Name: Stem Cell Ophthalmology Treatment Study II Condition: Retinal Disease Age-Related Macular Degeneration Retinitis Date: 2017-01-01 Interventions: Procedure: Arm 1 |
Recruiting |
Study Name: Biomechanics of Optic Neuropathy Condition: Optic Neuropathy Date: 2016-08-28 Interventions: Device: magnetic resonance image (MRI) |
Active, not recruiting |
Study Name: Safety and Efficacy of Using SightSaver Visual Evoked Potential (VEP) for VEP Monitoring in Prone Spine Surgery Condition: Ischemic Optic Neuropathy Date: 2015-12-11 Interventions: Device: VEP under TIVA Propofo |
Completed |
Study Name: Outcomes of Steroid and Oxygen Therapy Versus Placebo Therapy in Non-arteritic Anterior Ischemic Optic Neuropathy Condition: NAION( Non-arteritic Anterior Ischemic Optic Neuropathy) Date: 2015-05-07 Interventions: Drug: placebo gelatinous capsu |
Active, not recruiting |
Study Name: A Phase I Clinical Trial of DARC Condition: Glaucoma Ocular Hypertension Glaucoma, Suspect Date: 2015-03-04 Interventions: Drug: ANX776 Single intravenous injection |
Recruiting |
Study Name: Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) Condition: Nonarteritic Anterior Ischemic Optic Neuropathy Date: 2015-01-13 Interventions: Drug: QPI-1007 Injection - single low dose |
Active, not recruiting |
Study Name: Retrobulbar Triamcinolone Acetonide Injection in the Treatment of NA-AION Condition: Triamcinolone Acetonide Optic Neuropathy, Ischemic Date: 2014-12-29 Interventions: Drug: Triamcinolone Acetonide Drug: placeb |
Not yet recruiting |
Study Name: ENDOTHELION Study Group: Effect of Bosentan in NAION Patients Condition: Ischemic Optic Neuropathy Date: 2014-12-05 Interventions: Drug: bosentan treatment by bo |
Completed |
Study Name: Safety and Efficacy Study of RPh201 Treatment of Ischemic Optic Neuropathy (ION). Condition: Non-arteritic Ischemic Optic Neuropathy Optic Nerve Injuries Date: 2014-01-21 Interventions: Drug: RPh201 SC injection twic |